We are live on ! Find out more
AHCO icon

AdaptHealth

182 hedge funds and large institutions have $1.32B invested in AdaptHealth in 2023 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

509% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $2.09M

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

33% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 30

17% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 54

6% more funds holding

Funds holding: 172182 (+10)

5% less capital invested

Capital invested by funds: $1.38B → $1.32B (-$64.1M)

1.44% less ownership

Funds ownership: 82.17%80.73% (-1.4%)

Holders
182
Holders Change
+10
Holders Change %
+5.81%
% of All Funds
2.86%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
40
Increased
63
Reduced
54
Closed
30
Calls
$12.7M
Puts
$2.09M
Net Calls
+$10.6M
Net Calls Change
-$4.61M

AHCO Hedge Fund Activity: Q2 2023 in Review

182 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2023, worth a combined $1.32B — down 4.6% from $1.38B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new AHCO positions and 30 closed out — a net gain of 10 holders — while 63 added to existing stakes and 54 trimmed.

The largest buyer was Reinhart Partners, adding an estimated $23.8M. The largest seller was Sumitomo Mitsui Trust Group, cutting an estimated $33.7M.

  • 182 institutional investors held AdaptHealth (AHCO) as of Q2 2023, up from 172 in Q1 2023.
  • Funds reported $1.32B of AdaptHealth stock for Q2 2023, down 4.6% quarter-over-quarter.
  • 40 funds opened new AdaptHealth positions in Q2 2023 and 30 closed out, a net change of +10 holders.
  • The largest AdaptHealth buyer in Q2 2023 was Reinhart Partners, an estimated $23.8M added.
  • The largest AdaptHealth seller in Q2 2023 was Sumitomo Mitsui Trust Group, an estimated $33.7M sold.

Based on aggregated 13F filings for Q2 2023.